Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 88.5 +3 (+3.51%) Jul 22
At Loss
P/B:
15.18
Market Cap:
€ 7.55B ($ 8.59B)
Enterprise V:
€ 7.04B ($ 8.01B)
Volume:
208.00
Avg Vol (2M):
119.00
Trade In:

Spyre Therapeutics Inc Valuation Measures